title: Does intravitreal triamcinolone acetonide-assisted peeling of the internal limiting membrane effect the outcome of macular hole surgery?
abstract: OBJECTIVE
  To evaluate functional and anatomical outcome of triamcinolone acetonide assisted internal limiting membrane (ILM) peeling in patients with macular hole.
  
  
  METHODS
  Fifteen eyes of 15 consecutive patients were identified with stage 3 and 4 idiopathic macular holes, these undergoing triamcinolone acetonide assisted ILM peeling for macular holes. These were matched retrospectively with 15 eyes of 15 patients with stage 3 and 4 idiopathic macular holes of less than six months duration, who underwent macular hole surgery with ILM peel augmented with indocyanine green (ICG). Functional and anatomical outcomes were compared between two groups.
  
  
  RESULTS
  There were no significant differences between the two groups with reference to demographic features of age, sex, staging of the macular holes and the proportion subsequently undergoing cataract surgery. The mean follow-up period was 6.4 months in the triamcinolone acetonide group and 7.2 months in the ICG group. The hole closure rate was 100% in both group at primary operation. The mean Snellen line change was +1.24 in the intravitreal triamcinolone group and +1.1 in the ICG group. There was a significant improvement in Snellen and Logmar visual acuity in both groups. These differences in visual outcome between the groups were not statistically significant.
  
  
  CONCLUSIONS
  Our data showed similar outcomes for patients with macular hole where ICG has been used when compared to patients where triamcinolone acetonide has been used for ILM peeling. Further study with longer follow-up and large series is warranted to assess the safety of the triamcinolone acetonide assisted ILM peeling in macular hole surgery.
authors.affiliation: Istanbul Retina Institute, Inc., Hakki Yeten Cad. No:8/7, Sisli, 34349 Istanbul, Turkey. retina@pobox.com
authors.forename: Murat
authors.initials: M
authors.lastname: Karacorlu
authors.forename: Hakan
authors.initials: H
authors.lastname: Ozdemir
authors.forename: Serra
authors.initials: S
authors.lastname: Arf Karacorlu
mesh_terms: D001485:Basement Membrane / Q000473:pathology / Q000601:surgery; D016022:Case-Control Studies; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007208:Indocyanine Green; D008297:Male; D008875:Middle Aged; D012160:Retina / Q000473:pathology / Q000601:surgery*; D012167:Retinal Perforations / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery*; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide; D007208:Indocyanine Green
references.citation: Am J Ophthalmol. 2002 Nov;134(5):661-6
references.pmid: 12429240
references.citation: Arch Ophthalmol. 1997 Jan;115(1):11-21
references.pmid: 9006420
references.citation: Ophthalmology. 1994 Mar;101(3):534-41
references.pmid: 7510380
references.citation: Ophthalmology. 1999 Jul;106(7):1392-7; discussion 1397-8
references.pmid: 10406628
references.citation: Am J Ophthalmol. 2001 Mar;131(3):387-8
references.pmid: 11239880
references.citation: Am J Ophthalmol. 2002 Jan;133(1):89-94
references.pmid: 11755843
references.citation: Ophthalmology. 2003 Mar;110(3):604-8
references.pmid: 12623830
references.citation: Am J Ophthalmol. 2004 Jan;137(1):172-3
references.pmid: 14700661
references.citation: Arch Ophthalmol. 2000 Aug;118(8):1116-8
references.pmid: 10922208
references.citation: Retina. 2003 Dec;23(6):883-4
references.pmid: 14707850
references.citation: Invest Ophthalmol Vis Sci. 2003 Jan;44(1):370-7
references.pmid: 12506098
references.citation: Ophthalmology. 2001 Aug;108(8):1471-6; discussion 1477-8
references.pmid: 11470703
references.citation: Ophthalmology. 2000 Oct;107(10):1939-48; discussion 1948-9
references.pmid: 11013203
references.citation: Arch Ophthalmol. 2002 Jan;120(1):29-35
references.pmid: 11786054
references.citation: Retina. 2000;20(5):554-5
references.pmid: 11039438
references.citation: Am J Ophthalmol. 2001 Sep;132(3):433-5
references.pmid: 11530072
references.citation: Graefes Arch Clin Exp Ophthalmol. 2001 Jun;239(5):388-90
references.pmid: 11482344